Lv2
150 积分 2022-09-19 加入
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
1天前
已完结
Antibody - Drug Conjugates as a Novel Therapeutic Modality to Treat Recurrent Refractory Germ Cell Tumors
11天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
1个月前
已完结
Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody–Drug Conjugate
1个月前
已完结
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
OUP accepted manuscript
1个月前
已完结
Tissue Sample Preparation in LC‐MS Bioanalysis
1个月前
已完结
Yeast Display Guided Selection of pH-Dependent Binders
2个月前
已完结
Engineering pH-Sensitive Single-Domain Antibodies
2个月前
已完结
皖公网安备34019202002308
